Overview of Cefixime 200 mg

This section provides a clear, accurate description of the pharmaceutical entity, Cefixime 200 mg, defining its chemical composition, pharmacological classification, and general purpose without providing dosage or safety information.

Property	Description
Active ingredient	Cefixime
Form	Tablet or Oral suspension
Pharmacological class	Third-generation cephalosporin antibiotic
Common use	Eliminating bacterial infections
Origin	Semisynthetic

What Type of Medicine is Cefixime 200 mg? (Identity & Classification)

Cefixime 200 mg is a prescription-only, semisynthetic beta-lactam antibiotic belonging to the third-generation cephalosporin class. Cefixime acts as an antibiotic used to inhibit bacterial cell wall synthesis. The status of Cefixime as a third-generation agent is a key differentiator, indicating its broad-spectrum capability and its resistance to degradation by bacterial enzymes known as beta-lactamases, which neutralize older antibiotics. Its primary purpose is the effective treatment of susceptible bacterial populations.

Active Ingredient and Form: What is Cefixime 200 mg Made Of? (Composition & Form)

The sole active ingredient in this single-ingredient product is Cefixime, often prepared as its trihydrate salt. The 200 mg figure specifies the precise unit dose of Cefixime contained within the final dosage forms. This medicine is intended for oral administration and is commonly available as a film-coated tablet or a flavored oral suspension, making it suitable for different patient groups, including children, which is a differentiating feature from many injectable antibiotics. The chemical structure of Cefixime characterizes it as a potent compound.

What is the General Purpose of Taking Cefixime? (High-Level Purpose)

The general purpose of Cefixime is to exert a potent bactericidal effect that eliminates susceptible microbial pathogens from the body. It achieves this by disrupting the formation of the bacterial cell wall, which stops the growth and spread of bacterial infections. As a broad-spectrum antibiotic, its physiological action makes it a therapeutic tool against various bacterial infections, such as those affecting the middle ear or the throat. Its characteristic as an orally active third-generation agent provides a logistical benefit, allowing patients to complete their course of treatment outside of a clinical setting, once the bacterial load has been reduced.

Regulatory References

MedlinePlus

What side effects are possible with Cefixime 200 mg?

Possible Side Effects and Safety Information

The safety profile of Cefixime 200 mg is based on officially documented adverse reactions classified by frequency and affected physiological system, as reported in regulatory documents from health authorities like the FDA and EMA. This information addresses the officially recognized risks without providing clinical advice.

Classification of Adverse Reactions

The most frequently reported adverse reactions are commonly classified as Gastrointestinal disorders.

Frequency Classification	Examples of Adverse Reactions (SOC)
Common (≥1/100)	Diarrhea, Nausea, Abdominal pain, Vomiting, Headache
Uncommon (≥1/1,000)	Skin rash, Pruritus, Dizziness, Dyspepsia
Rare (≥1/10,000)	Drug fever, Transient increases in liver enzymes

Serious adverse reactions, though generally rare, are explicitly documented in regulatory labeling. These include severe immediate hypersensitivity reactions such as anaphylaxis and angioedema, along with severe cutaneous reactions like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Potential complications of the Infections and infestations system include Pseudomembranous colitis and superinfection due to the overgrowth of non-susceptible organisms, which may be associated with prolonged use.

Population-Specific Safety Considerations

Specific safety considerations are noted for certain patient populations. Patients with impaired renal function may require monitoring due to the drug's primary renal elimination. Official documents also caution patients with a history of colitis or known penicillin hypersensitivity, citing a heightened risk for Clostridium difficile-associated disease (CDAD) and cross-allergic reactions, respectively. Furthermore, the label notes that cephalosporins have been associated with a prolongation of prothrombin time, which is a safety constraint regarding coagulation.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below reflects the officially documented descriptions of Cefixime overdose found in government regulatory prescribing information and monographs.

In the event of a suspected or confirmed overdose, immediate medical attention must be sought or emergency services contacted. Treatment is defined strictly as symptomatic and supportive.

Documented Manifestations	Description of Risk
Gastrointestinal Effects	Overdose commonly presents with reversible symptoms such as diarrhea, nausea, vomiting, and abdominal pain.
Central Nervous System (CNS)	A large overdose carries the documented risk of reversible encephalopathy and seizures, representing potential CNS toxicity.

Special Overdose and Management Considerations

No Specific Antidote: Regulatory documents explicitly state that no specific antidote is known for Cefixime. Additionally, hemodialysis and peritoneal dialysis procedures are generally documented as not effective for removing the drug.
Renal Impairment: The risk and severity of neurological complications, including encephalopathy and seizures, are increased in patients with pre-existing renal impairment. Hospital monitoring may be required for high-risk patients.
Procedural Action: If seizures occur, the medication must be discontinued. Procedures such as gastric lavage may be indicated depending on the time of ingestion.

This information defines what regulatory authorities state about overdose presentation and the mandated emergency response.

Therapeutic Uses of Cefixime 200 mg

What Cefixime 200 mg Treats: Main Uses and Benefits

Cefixime is generally used for conditions involving bacterial infections, particularly when symptoms relate to physical discomfort or inflammatory states. This medication is applied across domains where additional symptomatic support is needed to address the underlying bacterial presence.

The medication is commonly used across conditions presenting with acute episodes, which include pharyngitis, tonsillitis, acute flare-ups of bronchitis, acute otitis media, and uncomplicated urinary tract infections (UTIs). The primary benefit is addressing symptom clusters that may become intense or disruptive, such as severe sore throat, significant earache (otalgia), and painful urination (dysuria).

This use contributes to improved comfort during periods of heightened symptoms. Furthermore, it is considered relevant in conditions where symptoms may intensify temporarily, including systemic bacterial diseases like typhoid fever, where it supports patients during difficult episodes. This agent is relevant in contexts involving heightened systemic burden, such as situations where patients require an effective oral treatment but have sensitivities to penicillin-class antibiotics.

“Cefixime is relevant for managing symptoms that interfere with daily comfort across common infections of the ear, throat, and urinary tract.”

Quick Fact: Relief for Acute Discomfort Cefixime is commonly used to help manage acute, localized symptoms like ear pain and painful urination in the context of susceptible bacterial infections.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Cefixime 200 mg — Official Regulatory Information

The eligibility for Cefixime 200 mg is determined strictly by the patient's population group and pre-existing conditions, as documented in official regulatory labeling.

Populations for Whom Use is Contraindicated

Patients with known hypersensitivity (allergy) to Cefixime or to other cephalosporin antibiotics.
Patients with Phenylketonuria (PKU) must avoid certain dosage forms, such as chewable tablets, that contain phenylalanine.

Age-Related and Conditional Eligibility Rules

Population Group	Regulatory Status
Infants under six months	Safety and effectiveness have not been established; use is not approved.
Children ge six months and Adults	Approved for use.
Renal Impairment	Use is permitted, but dose adjustment is required when creatinine clearance is less than 60 mL/min.
History of Penicillin Allergy	Use requires caution due to documented partial cross-allergenicity.
Pregnancy	Should be used only if clearly needed, as adequate human studies are lacking.
Lactation (Breastfeeding)	Consideration should be given to discontinuing nursing temporarily during treatment.

Official Eligibility Statements: The medicine is explicitly contraindicated based on beta-lactam allergy status. Use is limited by the patient's age, with approval starting at six months. Furthermore, regulatory documents specify that use requires caution in patients with a history of penicillin allergy, concurrent anticoagulant therapy, and when treating patients with impaired kidney function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cefixime has documented interaction considerations with a few specific medicine categories, primarily based on postmarketing surveillance.

Interacting Product Category	Specific Medicine(s)	Observed Effect and Mechanism
Anticoagulants	Warfarin and similar agents	Increased prothrombin time (coagulation time), with reports of bleeding. The mechanism is associated with a decrease in prothrombin activity. Monitoring of prothrombin time is suggested for at-risk patients, such as those with kidney or liver impairment, poor nutritional status, or those previously stabilized on anticoagulant therapy.
Anticonvulsants	Carbamazepine	Elevated Carbamazepine levels in the blood have been reported. The specific mechanistic basis for this increase is currently unknown. Drug monitoring is suggested to detect alterations in Carbamazepine plasma concentrations, which may require dose adjustment.
Vaccines (Live)	Typhoid Vaccine Live, BCG Vaccine Live, Cholera Vaccine	The concurrent use of Cefixime, a strong antibacterial, may potentially decrease the therapeutic efficacy of certain live bacterial vaccines. Consult a healthcare professional before combining Cefixime with these products.

Clinical and Laboratory Notes

Cefixime can lead to false-positive reactions for ketones in the urine when tests utilize nitroprusside. Additionally, severe diarrhea, sometimes occurring several weeks after stopping the medicine, may indicate a serious condition related to an overgrowth of C. difficile bacteria. Consult a health professional immediately if severe, persistent diarrhea occurs, and avoid anti-diarrhea products unless directed.

Mechanism of Action

Disruption via Irreversible Enzyme Inhibition

Cefixime's action is fundamentally bactericidal, resulting in the physical destruction of susceptible microbial pathogens. Its mechanism centers on binding to crucial bacterial enzymes called Penicillin-Binding Proteins (PBPs), particularly PBP-3, which are responsible for forming the structural support of the cell wall. Cefixime acts as an irreversible covalent inhibitor, neutralizing these PBPs by chemically bonding to their active site. This action immediately blocks the final step in the bacteria's process of building its cell wall—the peptidoglycan cross-linking pathway.

The Cascade of Cell Lysis

The molecular inhibition of PBPs triggers a cascade that leads to the drug's definitive physiological effect. The structural failure of the cell wall prevents the bacteria from withstanding the massive internal osmotic pressure. The result is a mechanical breakdown of the cell, leading to rapid swelling and rupture (cell lysis), which is the direct mechanism for the drug's bactericidal physiological effect. This mechanism of action is also structurally enhanced, as Cefixime's third-generation structure makes it inherently resistant to degradation by many bacterial beta-lactamase enzymes, resulting in a sustained bactericidal action.

Dosage and Administration Information

How to Use Cefixime 200 mg

Cefixime is designated for oral administration, utilizing dosage forms such as tablets, capsules, chewable tablets, or oral suspension. The medicine may be taken without regard to food.

Standard Dosing and Frequency

The most common total daily dose for adults is 400 mg, which can be administered in one of two ways. It may be taken as a single 400 mg dose once daily, or as 200 mg every 12 hours (twice daily). A single 400 mg dose is also specified for certain uncomplicated infections.

Patient Population	Standard Daily Regimen	Frequency Pattern
Adults (and Children > 45 kg)	400 mg total	Once daily or 200 mg twice daily
Children (ge 6 months)	8 mg/kg of body weight	Single daily dose or two divided doses

Administration Requirements and Duration

The total treatment duration typically ranges from 7 to 14 days, although a minimum course of at least 10 days is applied for infections involving Streptococcus pyogenes. Specific handling is required for certain forms: oral suspensions are shaken well before each measured administration, and chewable tablets are crushed or chewed prior to swallowing.

Dosing Adjustments for Renal Function

Dose modification is utilized for adults with severely impaired kidney function. For patients with a creatinine clearance of less than 20 mL/min or those on dialysis, the dose is typically reduced to 200 mg once daily. Standard practice involves taking a missed dose as soon as possible, without doubling the dose to compensate for the missed administration.

Recent Clinical Evidence

Cefixime is an oral third-generation cephalosporin antibiotic used to address bacterial infections in various parts of the body. The fundamental action of cephalosporins involves interfering with the production of the bacterial cell wall, leading to the breakdown and death of the bacterial cell. This mechanism provides activity against a range of Gram-negative and Gram-positive organisms.

Investigated Conditions and Efficacy

Clinical research has focused on the use of cefixime in several common bacterial infections. Studies have investigated its application in:

Acute Otitis Media (Middle Ear Infection): Cefixime has been investigated as an alternative to other common antibiotics, particularly in pediatric patients. Comparative trials have shown its efficacy to be similar to that of amoxicillin and cefaclor for treating acute otitis media in children.
Pharyngitis and Tonsillitis: Trials comparing short courses of cefixime to standard 10-day courses of penicillin have shown similar bacteriological eradication rates for Group A beta-hemolytic Streptococcus (GABHS).
Uncomplicated Urinary Tract Infections (UTIs): Studies have evaluated the role of cefixime in treating uncomplicated UTIs caused by susceptible organisms, such as E. coli and P. mirabilis. Its efficacy has been compared to other agents used for this indication.

Resistance and Safety Profile

Cefixime is noted for its stability against many beta-lactamase enzymes, which can otherwise cause resistance to penicillins and certain cephalosporins. However, clinical guidelines have changed regarding some uses, such as for gonorrhea, due to reports of rising Minimum Inhibitory Concentrations (MICs) among certain isolates. The most frequently reported adverse effects in clinical trials are mild to moderate gastrointestinal issues, such as diarrhea and loose stools, which are typically transient.

Frequently Asked Questions (FAQ)

Common questions about Cefixime 200 mg (FAQ)

Q: Can Cefixime 200 mg cause stomach issues like diarrhea?

A: Yes. According to official product information, effects on the stomach and intestines are among the most commonly reported adverse reactions. This frequently includes diarrhea and loose stools observed during clinical trials. These issues are often described as mild to moderate.

Q: Why does Cefixime 200 mg need to be taken for the full prescribed time?

A: Prescribing information for antibiotics, including Cefixime, emphasizes that they should only be used when a bacterial infection is present. Completing the full prescribed course is described as important for reducing the risk of developing drug-resistant bacteria. Using any antibacterial drug inappropriately can contribute to resistance.

Q: Can Cefixime 200 mg be used by people with kidney problems?

A: Yes, Cefixime may be used by people with kidney impairment. However, official labeling mandates a dose adjustment for patients whose kidney function (creatinine clearance) is below a certain level. This adjustment is required due to the drug's primary elimination route through the kidneys.

Q: What is the potential concern about Cefixime 200 mg and antibiotic resistance?

A: The primary concern with any antibiotic is the development of resistance. Official warnings state that prescribing Cefixime in the absence of a proven or strongly suspected bacterial infection increases the risk of bacteria developing resistance to the drug. For this reason, official indications limit its use to susceptible bacterial populations.

Q: What should be done if I suspect a mild side effect from Cefixime 200 mg?

A: Officially recognized common side effects, such as a mild headache, dizziness, nausea, or stomach pain, typically do not require immediate medical intervention. These effects are often temporary. If any reaction is severe or persistent, guidance from a health professional may be sought.

Q: How does Cefixime 200 mg differ from Amoxicillin?

A: Cefixime and Amoxicillin belong to different chemical groups of antibiotics. Cefixime is classified as a third-generation cephalosporin, while Amoxicillin is a penicillin-class drug. This classification difference means they have distinct chemical structures and often slightly varied spectra of activity against different types of bacteria.

Q: Is Cefixime 200 mg known as a 'strong' antibiotic?

A: Cefixime is officially classified as a third-generation cephalosporin, which is considered a broad-spectrum beta-lactam antibiotic. Third-generation agents are recognized for their stability against certain bacterial enzymes called beta-lactamases, which is one factor influencing its therapeutic role.

Q: What kinds of bacteria does Cefixime 200 mg typically target?

A: Cefixime is officially indicated for treating infections caused by specific, susceptible Gram-negative and Gram-positive organisms. This includes common pathogens like Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. It is indicated only for infections where these organisms are known or strongly suspected to be the cause.

Q: How long does it usually take for Cefixime 200 mg to start working?

A: Information on the drug's physical action shows that following oral administration, Cefixime generally reaches its highest concentration in the blood (peak serum levels) in approximately four hours. This physical presence of the drug in the bloodstream is distinct from the time it takes for a patient to observe symptom relief.

Q: Is a metallic taste a common side effect of Cefixime 200 mg?

A: Some reports gathered during post-marketing surveillance have mentioned a strange or metallic taste in the mouth as a possible adverse effect. However, this symptom is not listed among the most common adverse reactions frequently reported in the core clinical trials for the drug.

Q: Is it true that Cefixime 200 mg can sometimes affect blood test results?

A: Yes, official labeling notes that Cefixime can potentially interfere with certain laboratory tests. Specifically, it may lead to false-positive reactions for the presence of ketones in the urine when specific nitroprusside-based testing methods are used.

Q: Is Cefixime 200 mg generally considered safe for use during pregnancy?

A: Regulatory documents state that adequate and well-controlled human studies are lacking regarding the use of Cefixime in pregnant women. Official labeling indicates that the medicine is to be used only if clearly needed.

Q: How is Cefixime 200 mg related to other cephalosporin antibiotics?

A: Cefixime is classified as a third-generation cephalosporin antibiotic. This designation relates to its chemical structure and pharmacological profile, which provides an expanded spectrum of activity against many Gram-negative bacteria and increased stability against resistance enzymes compared to first- and second-generation agents.

Q: Does Cefixime 200 mg cause drowsiness or affect driving?

A: Official documents list dizziness and headache as reported side effects. These effects may potentially impact the ability to drive or operate complex machinery.

Q: What research evidence supports the use of Cefixime 200 mg for respiratory infections?

A: Clinical trials and official indications support the use of Cefixime for several respiratory conditions. This includes acute infections of the upper respiratory tract, such as otitis media (middle ear infection), pharyngitis (throat infection), tonsillitis, and acute exacerbations of chronic bronchitis.

Q: Is Cefixime 200 mg effective against viral infections?

A: No. Cefixime is categorized as an antibacterial agent. Its entire function is based on disrupting the formation of a bacterial cell wall. Official information clarifies that antibiotics are not effective against infections caused by viruses.

Q: Can Cefixime 200 mg lead to a yeast infection (thrush)?

A: The use of an antibiotic like Cefixime can sometimes disrupt the normal balance of microorganisms in the body. Official labeling notes the potential for superinfection, which is the overgrowth of non-susceptible organisms, including fungi (which cause yeast infections/thrush).

Q: Is it necessary to avoid alcohol completely while using Cefixime 200 mg?

A: No known adverse interaction between Cefixime and alcohol consumption is reported.

Q: Does Cefixime 200 mg interact with antacids or acid-reducing medications?

A: Studies examining the co-administration of Cefixime with common antacids have concluded that the antacids do not significantly alter or modify the absorption of Cefixime into the body.

Q: What happens if Cefixime 200 mg is taken with food or on an empty stomach?

A: Official labeling explicitly states that Cefixime may be administered without regard to food. The absorption rate of the medicine into the body is similar, whether it is taken with food or on an empty stomach.

Q: Is the 200 mg strength the only one available for Cefixime?

A: No. Cefixime is available in different dosage strengths and forms to suit various populations and dosing regimens. These commonly include 100 mg and 400 mg tablets or capsules, as well as a liquid oral suspension.

Q: How long does Cefixime 200 mg stay in the body after the last dose?

A: The elimination half-life is a measure of how quickly the body removes the drug. For Cefixime, the half-life in adults with normal kidney function is approximately 2.4 to 4 hours. The drug is primarily removed from the body via the kidneys.

Q: Is there a link between Cefixime 200 mg and liver issues?

A: Official documents note that transient (temporary) elevations in liver enzymes have been reported as a possible adverse effect. Very rare cases of more serious conditions like hepatitis or jaundice have also been observed during post-marketing surveillance.

Q: Can Cefixime 200 mg be used by older adults (geriatric patients)?

A: Yes, Cefixime is approved for use in adults, including the elderly population. Regulatory information suggests that no overall differences in effectiveness or safety were noted between older and younger adults. However, greater caution may be exercised with respect to existing kidney function in older adults.

Q: Is Cefixime 200 mg suitable for people with a history of seizures?

A: Central Nervous System effects, including seizures, have been reported during the post-marketing surveillance of this antibiotic class. Official information describes these effects as a known risk sometimes associated with cephalosporin antibiotics.

Q: Why is Cefixime 200 mg not used for certain types of infections?

A: Cefixime is officially indicated only for infections caused by specific, susceptible microorganisms. It is not used for infections caused by viruses, or when the bacteria present are known to be resistant to Cefixime.

Q: Why is Cefixime 200 mg sometimes prescribed when other antibiotics have failed?

A: Cefixime is a third-generation cephalosporin, a class known for its chemical structure which offers high stability against beta-lactamase enzymes. These enzymes are a common mechanism used by bacteria to develop resistance to older antibiotics, giving Cefixime a role when older-generation drugs are not effective.

Q: Is Cefixime 200 mg a widely studied drug?

A: Yes. The official labeling confirms that the approved indications for Cefixime are based on an extensive body of clinical research. This includes controlled trials and comparative studies that have established its use for conditions like middle ear infections and certain throat infections.

How should Cefixime 200 mg be stored and disposed of?

Storage Conditions

Cefixime 200 mg tablets must be stored at Controlled Room Temperature (CRT), typically defined as 20 C to 25 C (68 F to 77 F), and the temperature must not exceed 30 C. The medicine must be kept in its original container, which should be tightly closed to protect the contents from moisture and light. It is mandatory to keep the tablets away from excess heat and to keep them from freezing. For safety, the product must be stored out of the reach and sight of children.

Disposal Instructions

Unused or expired Cefixime 200 mg must be disposed of in accordance with local requirements for pharmaceutical waste. Medicines should not be thrown into household trash or disposed of via wastewater. The official guidance is to consult a healthcare professional or pharmacist for instructions on how to safely discard any unused medicine.

Cefixime 200 mg